Incidence:  The Multiple Sclerosis Foundation estimates that more than 400,000 people in the United States and about 2.5 million people around the world have MS. About 200 new cases are diagnosed each week in the United States. (http://www.healthline.com/health/multiple-sclerosis/facts-statistics-infographic#sthash.ulsNiamx.dpuf)

Medical Cannabis Indication:  Multiple Sclerosis

          Improves:  Neuropathic Pain, Quality of sleep, Muscle Relaxation

Recommended cannabinoid ratios:  

                     equal ratio THC: CBD (e.g. 1:1) 

                     high THC : low CBD (e.g. 20:1)

Dosing:  

Go slow and start dosing low and titrate until desired results are achieved.

 (Combination of  the above products may be required).  THC doses greater than 10mg/dose not recommended

Other:  

Neuroprotective properties may slow progression of disease.

Cannabinoid replacement therapy may reduce symptoms and prolong survival. 

(Please note that cannabinoid therapy is patient specific and may require dose/concentration adjustment. Please consult with your provider for appropriate therapy options.)

 

References: 

Journal Articles:

Cannabis for Multiple Sclerosis  

Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids (abstract only)